| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 8, 2005
Accepted on October 25, 2005
-Hydroxysteroid Dehydrogenase Gene Associated with Polycystic Ovary Syndrome
Departments of Pediatrics, Medicine, Human Genetics, and the Committee on Genetics. The University of Chicago, Chicago, IL. 60637
* To whom correspondence should be addressed. E-mail: kqin{at}peds.bsd.uchicago.edu.
Context. Polycystic ovary syndrome (PCOS) is characterized by chronic hyperandrogenic anovulation and is associated with insulin resistance. Its pathogenesis is believed to be multifactorial, and abnormal gene regulation could be one contributing factor. Type 5 17 
-hydroxysteroid dehydrogenase (17-HSD5) appears to be the major testosterone-forming 17-HSD isoenzyme in females.
Objective. To investigate the role of a potentially activating 17-HSD5 gene (HSD17B5) variant in hyperandrogenism.
Design. Case report and case-control cohort study.
Setting. General Clinical Research Center.
Study subjects. A case of PCOS who had hyperthecosis associated with profound type B insulin resistance and an unusual, frankly male, testosterone response to a gonadotropin releasing hormone agonist test, 121 PCOS, and 128 population controls.
Interventions. Diagnostic.
Main outcome measures. Sequencing of HSD17B5 5'-flanking region and 9 exons, genotype/phenotype studies, and in vitro functional studies.
Results. Our case had a previously undescribed homozygous HSD17B5 variant (G-to-A substitution) -71 bp in the promoter region. Genotyping controls showed this to be a single nucleotide polymorphism (SNP-71G). Luciferase activity of a SNP-71G promoter construct was significantly higher than that of the wild-type, and electrophoretic mobility shift assays revealed that SNP-71G possessed significantly increased affinity to nuclear transcription factors. SNP-71G allele frequency (32.2% vs. 22.3%) and SNP-71G allele homozygosity (10.7% vs. 6.25%) were significantly increased in PCOS (P = 0.012). SNP-71G homozygosity tended to contribute about 20% to the plasma testosterone level.
Conclusions. SNP-71G is a functional polymorphism that may contribute to testosterone excess in a subset of PCOS patients.
-HSD) •
Type 5 17-HSD gene (HSD17B5) •
electrophoretic mobility shift assays (EMSA) •
polycystic ovary syndrome (PCOS) •
stimulatory protein 1/3 (Sp1/Sp3) •
Single nucleotide polymorphism (SNP)
This article has been cited by other articles:
 |
|
 |
|
  J. M Day, H. J Tutill, A. Purohit, and M. J Reed Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis Endocr. Relat. Cancer, September 1, 2008; 15(3): 665 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Simoni, C.B. Tempfer, B. Destenaves, and B.C.J.M. Fauser Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response Hum. Reprod. Update, September 1, 2008; 14(5): 459 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Azziz Polycystic Ovary Syndrome Is a Family Affair J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1579 - 1581. [Full Text] [PDF]
|
|
|
|
|
|
M. O. Goodarzi, M. R. Jones, H. J. Antoine, M. Pall, Y.-D. I. Chen, and R. Azziz Nonreplication of the Type 5 17 -Hydroxysteroid Dehydrogenase Gene Association with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 300 - 303. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
